1. "I feel empowered": women's perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain. Issue 8 (9th August 2021) Authors: Mantsios, Andrea; Murray, Miranda; Karver, Tahilin S.; Davis, Wendy; Margolis, David; Kumar, Princy; Swindells, Susan; Bredeek, U. Fritz; Deltoro, Miguel García; García, Rafael Rubio; Antela, Antonio; Garris, Cindy; Shaefer, Mark; Gomis, Santiago Cenoz; Bernáldez, Miguel Pascual; Kerrigan, Deanna Journal: Culture, health & sexuality Issue: Volume 23:Issue 8(2021) Page Start: 1066 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1021. HIV-1 RNA Blips and Low-Level Replication During Phase III/IIIb Cabotegravir + Rilpivirine Long-Acting Studies Are Similar to Oral 3-Drug Therapy and Not Associated with Week 48 Virologic Outcome. (31st December 2020) Authors: Talarico, Christine L; Wu, Sterling; Upadhyay, Ojesh R; Clair, Marty St; Van Eygen, Veerle; Hudson, Krischan J; Griffith, Sandy; Harrington, Conn M; van Lunzen, Jan; Margolis, David; Spreen, William Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies. (31st December 2020) Authors: Teichner, Paula; Wu, Sterling; Zhang, Feifan; Dorey, David; D'Amico, Ronald; Griffith, Sandy; Sutton, Kenneth; McCoig, Cynthia C; Upadhyay, Ojesh R; Polli, Joseph; Margolis, David; Van Solingen-Ristea, Rodica; Vandermeulen, Kati; Spreen, William; Patel, Parul Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1035. Patient-Reported Outcomes on Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: FLAIR 96-Week Results. (31st December 2020) Authors: Chounta, Vasiliki; Bernal, Enrique; Lombaard, Johan; Katner, Harold P; Walmsley, Sharon; Dorey, David; Spreen, William; Griffith, Sandy; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV treatment in the US (CUSTOMIZE). (31st December 2020) Authors: Czarnogorski, Maggie; Garris, Cindy; Wannamaker, Paul; D'Amico, Ronald; Selenski, Carolyn; Williams, Will; McHorney, Colleen A; Stassek, Larissa; Wohlfeiler, Michael; Sinclair, Gary I; Mena, Leandro A; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 116. Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Hiv-positive Subjects: Results from the POLAR Study. (31st December 2020) Authors: Mills, Anthony; Richmond, Gary J; Newman, Cheryl; Osiyemi, Olayemi; Cade, Jerry; Brinson, Cynthia; De Vente, Jerome; Andany, Nisha; Margolis, David; Sutton, Kenneth; Wilches, Viviana; Roberts, Jeremy; McCoig, Cynthia C; Vandermeulen, Kati; Spreen, William Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 638. Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results. (31st December 2020) Authors: Smith, Graham; Henry, Keith; Podzamczer, Daniel; Masiá, Mar; Bettacchi, Christopher; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Sutton, Kenneth; Zhang, Feifan; McCoig, Cynthia C; Vandermeulen, Kati; Van Solingen-Ristea, Rodica; Spreen, William; Margolis, David Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 927: Sedated Lymphocyte and Stem Cell Collection With Dexmedetomidine. (January 2021) Authors: Magner, Kristin; Gedeit, Rainer; Redfern, Wendi; Dziedzic, Rachel; Buchman, Bo; Anderson, Lynnette; Margolis, David; DeVries, Lisa; Meyer, Michael Journal: Critical care medicine Issue: Volume 49:Supplement 1 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A real‐world experience with the bioactive human split thickness skin allograft for venous leg ulcers. Issue 4 (19th May 2020) Authors: Kirsner, Robert S.; Margolis, David; Masturzo, Arti; Bakewell, Katie Journal: Wound repair and regeneration Issue: Volume 28:Issue 4(2020) Page Start: 547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A-102 Antibody binding to HIV-1 infected cells as mechanism for treatment of HIV infection. (April 2018) Authors: Ferrari, Guido; Nordstrom, Jeffrey; Koenig, Scott; Sung, Julia; Margolis, David; Haynes, Barton Journal: Journal of acquired immune deficiency syndromes Issue: Volume 77(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗